Phase I clinical trial of lenalidomide in combination with 5-fluorouracil, leucovorin, and oxaliplatin in patients with advanced cancer
Conclusions
Lenalidomide in combination with FOLFOX was well tolerated. Four patients had prolonged stable disease. This combination merits further investigation for selected patient populations.
Source: Cancer Chemotherapy and Pharmacology - Category: Cancer & Oncology Source Type: research
More News: Cancer | Cancer & Oncology | Chemotherapy | Clinical Trials | Colorectal Cancer | Drugs & Pharmacology | Eloxatin | Gastric (Stomach) Cancer | Gastroenterology | Pancreas | Pancreatic Cancer | Revlimid | Study | Thrombocytopenia | Toxicology